WINTON GROUP Ltd lessened its position in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 0.8% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 60,540 shares of the financial services provider’s stock after selling 503 shares during the period. CME Group makes up approximately 0.9% of WINTON GROUP Ltd’s investment portfolio, making the stock its 17th largest position. WINTON GROUP Ltd’s holdings in CME Group were worth $14,059,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors and hedge funds have also made changes to their positions in the business. SJS Investment Consulting Inc. grew its holdings in CME Group by 570.6% during the 4th quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock valued at $26,000 after buying an additional 97 shares during the last quarter. Truvestments Capital LLC purchased a new stake in shares of CME Group in the third quarter valued at $26,000. Dunhill Financial LLC boosted its stake in shares of CME Group by 188.4% during the third quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock valued at $27,000 after acquiring an additional 81 shares during the last quarter. Financial Life Planners acquired a new stake in shares of CME Group during the fourth quarter valued at $32,000. Finally, Knuff & Co LLC purchased a new stake in CME Group during the 4th quarter worth about $33,000. 87.75% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
CME has been the topic of several analyst reports. Keefe, Bruyette & Woods raised their price target on shares of CME Group from $256.00 to $257.00 and gave the stock a “market perform” rating in a research note on Friday, February 14th. Erste Group Bank raised shares of CME Group to a “strong-buy” rating in a research note on Monday, March 17th. Morgan Stanley lifted their target price on shares of CME Group from $256.00 to $263.00 and gave the stock an “equal weight” rating in a research note on Wednesday, February 19th. Citigroup lowered CME Group from a “buy” rating to a “neutral” rating and reduced their price target for the stock from $255.00 to $250.00 in a research note on Monday, January 6th. Finally, Oppenheimer lifted their price objective on CME Group from $258.00 to $269.00 and gave the company an “outperform” rating in a research report on Thursday, February 13th. Four analysts have rated the stock with a sell rating, eight have issued a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $238.93.
CME Group Stock Performance
CME Group stock opened at $262.72 on Thursday. The firm has a market capitalization of $94.67 billion, a PE ratio of 27.17, a price-to-earnings-growth ratio of 6.76 and a beta of 0.53. CME Group Inc. has a one year low of $190.70 and a one year high of $267.91. The stock’s 50 day moving average price is $248.47 and its 200 day moving average price is $235.14. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.01.
CME Group (NASDAQ:CME – Get Free Report) last announced its earnings results on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share for the quarter, beating the consensus estimate of $2.46 by $0.06. CME Group had a net margin of 57.52% and a return on equity of 13.62%. As a group, sell-side analysts expect that CME Group Inc. will post 10.49 EPS for the current fiscal year.
CME Group Increases Dividend
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, March 26th. Shareholders of record on Friday, March 7th were given a $1.25 dividend. This is a boost from CME Group’s previous quarterly dividend of $1.15. This represents a $5.00 dividend on an annualized basis and a yield of 1.90%. The ex-dividend date was Friday, March 7th. CME Group’s dividend payout ratio is presently 51.71%.
CME Group declared that its Board of Directors has approved a share buyback program on Thursday, December 5th that authorizes the company to buyback $3.00 billion in shares. This buyback authorization authorizes the financial services provider to repurchase up to 3.4% of its stock through open market purchases. Stock buyback programs are generally an indication that the company’s board of directors believes its shares are undervalued.
Insider Transactions at CME Group
In other CME Group news, COO Suzanne Sprague sold 1,500 shares of the stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $256.83, for a total transaction of $385,245.00. Following the transaction, the chief operating officer now owns 8,036 shares of the company’s stock, valued at $2,063,885.88. This trade represents a 15.73 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Julie Winkler sold 11,592 shares of the firm’s stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $249.17, for a total value of $2,888,378.64. Following the transaction, the insider now owns 21,885 shares in the company, valued at $5,453,085.45. This trade represents a 34.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 27,076 shares of company stock valued at $6,871,496. 0.30% of the stock is currently owned by insiders.
CME Group Company Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
See Also
- Five stocks we like better than CME Group
- Dividend Capture Strategy: What You Need to Know
- Energy Transfer: Powering Data With Dividends and Diversification
- The Most Important Warren Buffett Stock for Investors: His Own
- Qualcomm Stock Is Coiling for a Breakout
- Best Stocks Under $5.00
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.